Boston University | GenomeWeb

Boston University

The investigators will conduct a longitudinal study of former athletes with high and medium exposure to repetitive head trauma, including former NFL players.

Public health researchers argue in NEJM that precision medicine initiatives will take away from needed efforts to improve population health.

Aperiomics launched its commercial sequencing and bioinformatics-based pathogen detection service at the annual meeting of the Association for Molecular Pathology last week, with three offerings: Absolute-ID, Absolute-Discovery, and Absolute-Biome.

NEW YORK (GenomeWeb) — A US-Israeli team has developed an improved optical method for reading out the ion current through solid-state nanopores, providing an alternative to present approaches for nanopore sequencing that use electrical measurements.

Packaging isothermal PCR reagents in blisters and using lateral flow detection, researchers at Boston University hope to develop a low-cost, disposable assay for Bordetella pertussis, the causative agent of whooping cough.

NEW YORK (GenomeWeb News) – Two studies appearing in the American Journal of Human Genetics today uncovered a handful of low-frequency variants, including novel variants in ANGPTL8, PNPLA5, and PCSK7, among others, that seem to contribute to cholesterol or lipid levels in the blood.

NEW YORK (GenomeWeb News) – Boston University has proposed building a new research center that will house interdisciplinary life sciences research projects involving systems and synthetic biology and neuroscience.

Bay Area molecular diagnostics shop Wave 80 Biosciences is gearing up to evaluate its first product — a semi-quantitative HIV viral load assay that runs on the company's cartridge-based, near-patient, sample-to-answer testing system — in full-scale clinical trials by the end of t

NEW YORK (GenomeWeb News) – A meta-analysis of genome-wide association studies has uncovered seven new loci linked to increased risk of age-related macular degeneration, the AMD Gene Consortium reported in Nature Genetics yesterday.

Lawyers challenging Myriad Genetics' patents underlying its BRACAnalysis genetic test have made no secret of the fact that a similar case could very well have been brought against Athena Diagnostics.

Pages

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.